Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: A Role for a tRNA fragment as a primer for reverse transcriptase

Journal of Virology

Volumn 88, Issue 7, 2014, Pages 3612-3622

  Ruggero, Katia ^a,f   Guffanti, Alessandro ^b   Corradin, Alberto ^a   Sharma, Varun Kumar ^a   De Bellis, Gianluca ^c   Corti, Giorgio ^c,g   Grassi, Angela ^d   Zanovello, Paola ^a,d   Bronte, Vincenzo ^e   Ciminale, Vincenzo ^a,d   D'Agostino, Donna M ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Genomnia   (Italy)

^c INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

^d VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^e UNIVERSITY HOSPITAL OF VERONA   (Italy)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PROLINE; RNA DIRECTED DNA POLYMERASE; SMALL UNTRANSLATED RNA; TRANSFER RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME ASSAY; GENE EXPRESSION; GENE LIBRARY; GENOME ANALYSIS; HUMAN T CELL LEUKEMIA VIRUS 1; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; VIRION; VIRUS DETECTION; VIRUS GENOME; VIRUS PARTICLE;

CD4-POSITIVE T-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; HOST-PATHOGEN INTERACTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; REVERSE TRANSCRIPTION; RNA, SMALL UNTRANSLATED; RNA, TRANSFER, PRO; RNA-DIRECTED DNA POLYMERASE;

EID: 84895421991     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02823-13     Document Type: Article

References (63)

1. Franchini G, Nicot C, Johnson JM. 2003. Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. Adv. Cancer Res. 89:69-132. http://dx.doi.org/10.1016/S0065-230X(03)01003-0.
2. Matsuoka M. 2003. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 22:5131-5140. http://dx.doi.org/10.1038/sj.onc.12 06551.
3. Lairmore M, Franchini G. 2007. Human T-cell leukemia virus types 1 and 2, p 2071-2106. In Knipe DM, HowleyPM(ed), Fields virology, 5th ed, vol 2. Lippincott Williams and Wilkins, Philadelphia, PA.
4. Lairmore MD, Anupam R, Bowden N, Haines R, Haynes RAH, Ratner L, Green P. 2011. Molecular determinants of human T-lymphotropic virus type 1 transmission and spread. Viruses 3:1131-1165. http://dx.doi .org/10.3390/v3071131.
5. Matsuoka M, Jeang KT. 2011. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 30:1379-1389. http://dx.doi.org/10.1038/onc.2010 .537.
6. Hasegawa H, Sawa H, Lewis MJ, Orba Y, Sheehy N, Yamamoto Y, Ichinohe T, Tsunetsugu-Yokota Y, Katano H, Takahashi H, Matsuda J, Sata T, Kurata T, Nagashima K, Hall WW. 2006. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human Tlymphotropic virus type I. Nat. Med. 12:466-472. http://dx.doi.org/10 .1038/nm1389.
7. Satou Y, Yasunaga J, Yoshida M, Matsuoka M. 2006. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl. Acad. Sci. U. S. A. 103:720-725. http://dx.doi .org/10.1073/pnas.0507631103.
8. Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N, Yamaguchi T, Ono M, Sakaguchi S, Matsuoka M. 2011. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 7:e1001274. http://dx.doi .org/10.1371/journal.ppat.1001274.
9. Van Prooyen N, Andresen V, Gold H, Bialuk I, Pise-Masison C, Franchini G. 2010. Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins. Mol. Aspects Med. 31:333-343. http://dx.doi.org/10.1016/j .mam.2010.07.001.
10. Silic-Benussi M, Biasiotto R, Andresen V, Franchini G, D'Agostino DM, Ciminale V. 2010. HTLV-1 p13, a small protein with a busy agenda. Mol. Aspects Med. 31:350-358. http://dx.doi.org/10.1016/j.mam.2010.03 .001.
11. Fukumoto R, Andresen V, Bialuk I, Cecchinato V, Walser JC, Valeri VW, Nauroth JM, Gessain A, Nicot C, Franchini G. 2009. In vivo genetic mutations define predominant functions of the human T-cell leukemia/ lymphoma virus p12I protein. Blood 113:3726-3734. http://dx.doi.org/10 .1182/blood-2008-04-146928.
12. Huntzinger E, Izaurralde E. 2011. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 12:99-110. http://dx.doi.org/10.1038/nrg2936.
13. Iorio MV, Croce CM. 2012. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 4:143-159. http://dx.doi.org/10.1002/emmm.201100209.
14. Pichler K, Schneider G, Grassmann R. 2008. MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology 5:100. http://dx.doi .org/10.1186/1742-4690-5-100.
15. Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N, Matsuoka M, Jeang KT. 2008. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res. 68:8976-8985. http://dx.doi.org/10.1158/0008-5472.CAN-08-0769.
16. Bellon M, Lepelletier Y, Hermine O, Nicot C. 2009. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 113:4914-4917. http://dx.doi.org /10.1182/blood-2008-11-189845.
17. Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, Matsuda Y, Matsubara A, Muto S, Utsunomiya A, Yamaguchi K, Uchimaru K, Ogawa S, Watanabe T. 2012. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kB pathway in adult T-cell leukemia and other cancers. Cancer Cell 21:121-135. http://dx.doi.org/10.1016/j .ccr.2011.12.015.
18. Kincaid RP, Sullivan CS. 2012. Virus-encoded microRNAs: an overview and a look to the future. PLoS Pathog. 8:e1003018. http://dx.doi.org/10 .1371/journal.ppat.1003018.
19. Kincaid RP, Burke JM, Sullivan CS. 2012. RNA virus microRNA that mimics a B-cell oncomiR. Proc. Natl. Acad. Sci. U. S. A. 109:3077-3082. http://dx.doi.org/10.1073/pnas.1116107109.
20. Rosewick N, Momont M, Durkin K, Takeda H, Caiment F, Cleuter Y, Vernin C, Mortreux F, Wattel E, Burny A, Georges M, Van den Broeke A. 2013. Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma. Proc. Natl. Acad. Sci. U. S. A. 110:2306-2311. http://dx.doi.org/10.1073/pnas.1213842110.
21. Li SC, Shiau CK, Lin WC. 2008. Vir-Mir db: prediction of viral microRNA candidate hairpins. Nucleic Acids Res. 36:D184-D189. http: //dx.doi.org/10.1093/nar/gkm610.
22. Lee YS, Shibata Y, Malhotra A, Dutta A. 2009. A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev. 23:2639-2649. http://dx.doi.org/10.1101/gad.1837609.
23. Cole C, Sobala A, Lu C, Thatcher SR, Bowman A, Brown JW, Green PJ, Barton GJ, Hutvagner G. 2009. Filtering of deep sequencing data reveals the existence of abundant Dicer-dependent small RNAs derived from tRNAs. RNA 15:2147-2160. http://dx.doi.org/10.1261/rna.1738409.
24. Maute RL, Schneider C, Sumazin P, Holmes A, Califano A, Basso K, Dalla-Favera R. 2013. tRNA-derived microRNA modulates proliferation and theDNAdamage response and is down-regulated in B cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 110:1404-1409. http://dx.doi.org/10.1073 /pnas.1206761110.
25. Popovic M, Lange-Wantzin G, Sarin PS, Mann D, Gallo RC. 1983. Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. Proc. Natl. Acad. Sci. U. S. A. 80:5402-5406. http://dx.doi.org/10.1073/pnas.80.17.5402.
26. Lau NC, Lim LP, Weinstein EG, Bartel DP. 2001. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294:858-862. http://dx.doi.org/10.1126/science.1065062.
27. Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, Mussolin L, Ruggero K, Bonanno L, Guffanti A, De Bellis G, Gerosa G, Stellin G, D'Agostino DM, Basso G, Bronte V, Indraccolo S, Amadori A, Zanovello P. 2011. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood 117:7053-7062. http://dx.doi.org/10.1182/blood-2010-12-326629.
28. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL. 2009. BLAST+: architecture and applications. BMC Bioinformatics 10:421. http://dx.doi.org/10.1186/1471-2105-10-421.
29. Pearson WR, Lipman DJ. 1988. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. U. S. A. 85:2444-2448. http://dx.doi .org/10.1073/pnas.85.8.2444.
30. Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139-140. http://dx.doi.org/10.1093/bioinformatics /btp616.
31. Friedlander MR, Chen W, Adamidi C, Maaskola J, Einspanier R, Knespel S, Rajewsky N. 2008. Discovering microRNAs from deep sequencing data using miRDeep. Nat. Biotechnol. 26:407-415. http://dx .doi.org/10.1038/nbt1394.
32. Kimata JT, Wong FH, Wang JJ, Ratner L. 1994. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology 204:656-664. http://dx.doi.org/10.1006/viro.1994 .1581.
33. Balestrieri E, Pizzimenti F, Ferlazzo A, Giofre SV, Iannazzo D, Piperno A, Romeo R, Chiacchio MA, Mastino A, Macchi B. 2011. Antiviral activity of seed extract from Citrus bergamia towards human retroviruses. Bioorg. Med. Chem. 19:2084-2089. http://dx.doi.org/10.1016/j.bmc .2011.01.024.
34. Frezza C, Balestrieri E, Marino-Merlo F, Mastino A, Macchi B. 2014. A novel, cell-free PCR-based assay for evaluating the inhibitory activity of antiretroviral compounds against HIV reverse transcriptase. J. Med. Virol. 86:1-7. http://dx.doi.org/10.1002/jmv.23748.
35. Sharbati-Tehrani S, Kutz-Lohroff B, Bergbauer R, Scholven J, Einspanier R. 2008. miR-Q: a novel quantitative RT-PCR approach for the expression profiling of smallRNAmolecules such asmiRNAsin a complex sample.BMC Mol. Biol. 9:34. http://dx.doi.org/10.1186/1471-2199-9-34.
36. Kumarswamy R, Volkmann I, Thum T. 2011. Regulation and function of miRNA-21 in health and disease. RNA Biol. 8:706-713. http://dx.doi.org /10.4161/rna.8.5.16154.
37. Toyoshima H, Itoh M, Inoue J, Seiki M, Takaku F, Yoshida M. 1990. Secondary structure of the human T-cell leukemia virus type 1 rexresponsive element is essential for rex regulation of RNA processing and transport of unspliced RNAs. J. Virol. 64:2825-2832.
38. Seiki M, Hattori S, Yoshida M. 1982. Human T-cell leukemia virus: molecular cloning of the provirusDNAand the unique terminal structure. Proc. Natl. Acad. Sci. U. S. A. 79:6899-6902. http://dx.doi.org/10.1073 /pnas.79.22.6899.
39. Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, Cook T, Smale ST, Sakaguchi S, Livesey FJ, Fisher AG, Merkenschlager M. 2006. A role for Dicer in immune regulation. J. Exp. Med. 203:2519-2527. http://dx.doi .org/10.1084/jem.20061692.
40. Ballabio E, Mitchell T, van Kester MS, Taylor S, Dunlop HM, Chi J, Tosi I, Vermeer MH, Tramonti D, Saunders NJ, Boultwood J, Wainscoat JS, Pezzella F, Whittaker SJ, Tensen CP, Hatton CS, Lawrie CH. 2010. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood 116:1105-1113. http://dx.doi.org/10.1182 /blood-2009-12-256719.
41. Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K, Kume M, Kameoka Y, Takahashi N, Nakagawa T, Shimizu N, Sawada K. 2011. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 25:1324-1334. http://dx.doi.org/10.1038/leu.2011.81.
42. D'Agostino DM, Zanovello P, Watanabe T, Ciminale V. 2012. The microRNA regulatory network in normal-and HTLV-1-transformed T cells. Adv. Cancer Res. 113:45-83. http://dx.doi.org/10.1016/B978-0-12-394280-7.00002-6.
43. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. 2008. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40:43-50. http: //dx.doi.org/10.1038/ng.2007.30.
44. Ramsay RG, Gonda TJ. 2008. MYB function in normal and cancer cells. Nat. Rev. Cancer 8:523-534. http://dx.doi.org/10.1038/nrc2439.
45. Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H. 2007. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13:1241-1247. http://dx.doi.org/10.1038/nm1639.
46. Ruggero K, Corradin A, Zanovello P, Amadori A, Bronte V, Ciminale V, D'Agostino DM. 2010. Role of microRNAs in HTLV-1 infection and transformation. Mol. Aspects Med. 31:367-382. http://dx.doi.org/10.1016 /j.mam.2010.05.001.
47. Tomita M, Tanaka Y, Mori N. 2012. MicroRNA miR-146a is induced by HTLV-1 Tax and increases the growth of HTLV-1-infected T-cells. Int. J. Cancer 130:2300-2309. http://dx.doi.org/10.1002/ijc.25115.
48. Taganov KD, Boldin MP, Chang KJ, Baltimore D. 2006. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103:12481-12486. http://dx.doi.org/10.1073/pnas.0605298103.
49. Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, Fulci V, Franceschini D, Meloni F, Barnaba V, Macino G. 2010. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115:265-273. http://dx.doi.org/10.1182/blood-2009-06-225987.
50. Labbaye C, Spinello I, Quaranta MT, Pelosi E, Pasquini L, Petrucci E, Biffoni M, Nuzzolo ER, Billi M, Foa R, Brunetti E, Grignani F, Testa U, Peschle C. 2008. A three-step pathway comprising PLZF/miR-146a/ CXCR4 controls megakaryopoiesis. Nat. Cell Biol. 10:788-801. http://dx .doi.org/10.1038/ncb1741.
51. van Kester MS, Ballabio E, Benner MF, Chen XH, Saunders NJ, van der Fits L, van Doorn R, Vermeer MH, Willemze R, Tensen CP, Lawrie CH. 2011. miRNA expression profiling of mycosis fungoides. Mol. Oncol. 5:273-280. http://dx.doi.org/10.1016/j.molonc.2011.02.003.
52. Zhang H, Luo XQ, Zhang P, Huang LB, Zheng YS, Wu J, Zhou H, Qu LH, Xu L, Chen YQ. 2009. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One 4:e7826. http://dx.doi.org/10.1371/journal.pone.00 07826.
53. Hermeking H. 2010. The miR-34 family in cancer and apoptosis. Cell Death Differ. 17:193-199. http://dx.doi.org/10.1038/cdd.2009.56.
54. Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, Bonnal RJ, Birolo RS, Moro M, Crosti MC, Gruarin P, Maglie S, Marabita F, Mascheroni D, Parente V, Comelli M, Trabucchi E, De Francesco R, Geginat J, Abrignani S, Pagani M. 2011. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+T cells by the microRNA miR-125b. Nat. Immunol. 12:796-803. http://dx .doi.org/10.1038/ni.2057.
55. Mrazek J, Kreutmayer SB, Grasser FA, Polacek N, Huttenhofer A. 2007. Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res. 35:e73. http: //dx.doi.org/10.1093/nar/gkm244.
56. Cameron JE, Fewell C, Yin Q, McBride J, Wang X, Lin Z, Flemington EK. 2008. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 382:257-266. http://dx.doi.org/10.1016/j .virol.2008.09.018.
57. Mizuguchi Y, Mishima T, Yokomuro S, Arima Y, Kawahigashi Y, Shigehara K, Kanda T, Yoshida H, Uchida E, Tajiri T, Takizawa T. 2011. Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma. PLoS One 6:e15304. http://dx.doi.org/10.1371/journal.pone.0015304.
58. Dutta KK, Zhong Y, Liu YT, Yamada T, Akatsuka S, Hu Q, Yoshihara M, Ohara H, Takehashi M, Shinohara T, Masutani H, Onuki J, Toyokuni S. 2007. Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci. 98:1845-1852. http://dx .doi.org/10.1111/j.1349-7006.2007.00619.x.
59. Schopman NC, Heynen S, Haasnoot J, Berkhout B. 2010. A miRNAtRNA mix-up: tRNA origin of proposed miRNA. RNA Biol. 7:573-576. http://dx.doi.org/10.4161/rna.7.5.13141.
60. Abbink TE, Berkhout B. 2008. HIV-1 reverse transcription initiation: a potential target for novel antivirals? Virus Res. 134:4-18. http://dx.doi.org /10.1016/j.virusres.2007.12.009.
61. Beerens N, Berkhout B. 2002. Switching the in vitro tRNA usage of HIV-1 by simultaneous adaptation of the PBS and PAS. RNA 8:357-369. http: //dx.doi.org/10.1017/S1355838202028194.
62. Beerens N, Jepsen MD, Nechyporuk-Zloy V, Kruger AC, Darlix JL, Kjems J, Birkedal V. 2013. Role of the primer activation signal in tRNA annealing onto the HIV-1 genome studied by single-molecule FRET microscopy. RNA 19:517-526. http://dx.doi.org/10.1261/rna.035733.112.
63. Stewart-Maynard KM, Cruceanu M, Wang F, Vo MN, Gorelick RJ, Williams MC, Rouzina I, Musier-Forsyth K. 2008. Retroviral nucleocapsid proteins display nonequivalent levels of nucleic acid chaperone activity. J. Virol. 82:10129-10142. http://dx.doi.org/10.1128/JVI.01169-08.